XML 27 R17.htm IDEA: XBRL DOCUMENT

NOTE 11 - LIABILITY TO ISSUE COMMON STOCK	3 Months Ended
Mar. 31, 2020
Notes to Financial Statements
(11) LIABILITY TO ISSUE COMMON STOCK	(11) LIABILITY TO ISSUE COMMON STOCK During the fourth quarter 2018 and second quarter 2019 the Company entered into four (4) Securities Purchase Agreements, (SPAs), with three parties, two of whom are related to each other. All four of these SPAs have language prohibiting the holder to own more than 4.99% of the issued and outstanding shares of the Company at any time. In connection with these SPAs the Company was entitled to receive $906,500 in cash for the issuance of common stock, issuable at per share prices ranging between $0.0035 and $0.06 per share subject to downward adjustment based on volume weighted average price as defined at the date of issuance notice. The Company received $249,000 in 2018 and $310,000 in 2019 under these SPAs. The Company has not received the final September 2019 tranche of $347,500 as required under one of the SPAs. Contractually, under the SPAs, the Company is required to issue 88,619,381 shares. During the third quarter of 2019, 1,537,246 shares were issued under one of these SPAs. (See Note 16a)

NOTE 11 - LIABILITY TO ISSUE COMMON STOCK

3 Months Ended

Mar. 31, 2020

During the fourth quarter 2018 and second quarter 2019 the Company entered into four (4) Securities Purchase Agreements, (SPAs), with three parties, two of whom are related to each other. All four of these SPAs have language prohibiting the holder to own more than 4.99% of the issued and outstanding shares of the Company at any time.

In connection with these SPAs the Company was entitled to receive $906,500 in cash for the issuance of common stock, issuable at per share prices ranging between $0.0035 and $0.06 per share subject to downward adjustment based on volume weighted average price as defined at the date of issuance notice. The Company received $249,000 in 2018 and $310,000 in 2019 under these SPAs. The Company has not received the final September 2019 tranche of $347,500 as required under one of the SPAs. Contractually, under the SPAs, the Company is required to issue 88,619,381 shares. During the third quarter of 2019, 1,537,246 shares were issued under one of these SPAs. (See Note 16a)